Cointime

  • Новости
  • заголовки
  • Кавычки
  • Столбец
  • Активность
  • Bitcoin $71,140.13 -0.37%
  • Ethereum $2,103.95 -0.65%
  • BNB $656.97 -0.64%
  • Optimism $0.13 +1.30%
  • Arbitrum $0.10 -1.19%
  • Solana $88.48 -1.29%
  • Polygon $0.22 +2.77%
  • Cosmos $1.88 +1.85%
  • Avalanche $9.73 -2.09%
  • Bitcoin $71,140.13 -0.37%
  • Ethereum $2,103.95 -0.65%
  • BNB $656.97 -0.64%
  • Optimism $0.13 +1.30%
  • Arbitrum $0.10 -1.19%
  • Solana $88.48 -1.29%
  • Polygon $0.22 +2.77%
  • Cosmos $1.88 +1.85%
  • Avalanche $9.73 -2.09%
Home / Nimbus Therapeutics / investors

Nimbus Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
7
17
Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Access Biotechnology - Series Unknown
Atlas Venture - Series Unknown
Bain Capital Life Sciences - Series Unknown
Bill Gates - Series Unknown
Biotechnology Value Fund - Series Unknown
Lightstone Ventures - Series Unknown
Pfizer Venture Investments - Series Unknown
RA Capital Management - Series Unknown
SR One - Series Unknown
SV Health Investors - Series Unknown
Commodore Capital - Series Unknown
Logos Capital - Series Unknown
Surveyor Capital - Series Unknown
BVF Partners - Series Unknown
Lilly Ventures - Series C
Schrödinger - Series C
Richard Friesner - Seed

Contact

Cambridge,Massachusetts,United States
(857) 999-2009
Cointime
Содержание
  • Новости
  • венчурный капитал
  • Отраслевые исследования
  • наука и технология
  • Активность
компания
  • о нас
  • Рекламное сотрудничество
  • Отказ от ответственности
  • © 2023 Cointime. все права защищены
  • политика конфиденциальности
  • Условия использования